Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Advanced Therapies 2020 | LUMEVOQ: gene therapy for Leber hereditary optic neuropathy

Magali Taiel, MD, of GenSight Biologics, Paris, France, discusses LUMEVOQ gene therapy for patients with Leber hereditary optic neuropathy, a mitochondrial inherited form of vision loss. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).